Journal of Allergy and Clinical Immunology

Article	Citations
Cover 1	379
Oral mucosa effectively protects against peanut allergy in mice	295
Bile Acids Enriched In Young Children Who Developed Remission On Oral Immunotherapy	256
Table of Contents	219
News & Notes-AAAAI	202
Virtual Home Food Introduction- Safe, Alternative Method for Toddlers in the Childhood Activities Nutrition and Development Oversight (CAN DO) Study	193
To Inject or Not to Inject, That is the Question. Improving Epinephrine Auto-Injector Knowledge Among USF Residents: A Quality Improvement Initiative	190
Impact of Sublingual Immunotherapy on Aeroallergen-Specific IgE Concentrations in Pediatric Food Allergy Patients	172
Usefulness of the conjunctival allergen provocation test in the diagnosis of patients with different phenotypes of allergic rhinitis and conjunctival symptoms	150
Immune Globulin Subcutaneous 16.5% in Immunoglobulin-Naïve Patients with Primary Immunodeficiency	131
Idiopathic postprandial abdominal symptoms indistinguishable from Irritable Bowel Syndrome are responsive to antihistamines	129
Sex-specific and long-term trends of asthma, allergic rhinitis, and atopic dermatitis in South Korea, 2007-2022: a nationwide representative study	127
Preclinical and Pharmacokinetic Characterization of APG333: A Fully Human Monoclonal Antibody that Binds TSLP with High Affinity and Potently Inhibits Downstream Signaling	125
Immunophenotyping of Blood Monocytes in Patients in Both Chronic Schizophrenia and First Episode Psychosis Demonstrates Pro-Inflammatory Changes	124
A Global Survey Evaluating Barriers To Prescribing Biologics For Atopic Diseases During Pregnancy	121
Predictors of Alexithymia in Chronic Urticaria: The Role of Mental Comorbidities, Quality of Life, and Antihistamine Use	110
Effects of Type 3 and Neutrophilic Inflammation on Type 2 Chronic Rhinosinusitis with Nasal Polyps	109
Editorial Board	103
Automated Real Time Identification and Quantification of Pollen	102
Evolution Of Long-Term Prophylaxis In Patients With Hereditary Angioedema With C1 Inhibitor Deficiency, A 10-year Real-Life Experience In A Spanish Cohort	98
Regulation of T cell polarization using HIF1a stabilizer, Roxadustat in MC903 induced Atopic Dermatitis	96
HLA Matching is Not Required For T-Cell Engraftment Following Cultured Thymic Tissue Implantation (CTTI) in Children with Congenital Athymia	95
Title Page	94
Role of syntaxin-2 in asthma pathogenesis	94
Inhibition of Staphylococcus aureus-induced Mast cell/ basophils Activation via Regulation of PI3K/AKT Pathway by Small Molecule Compound Berberine (BBR).	93

Immunophenotyping Of Circulating Eosinophils In Patients With Hypereosinophilic Syndrome	91
PPAR-γ Suppresses Macrophage Senescence and Mitigates Allergic Airway Inflammation in Asthma	91
Longitudinal analysis of IgE levels in IgE deficient individuals	90
SMART Asthma Action Plan Implementation: A Quality Improvement Project	90
Penicillin Allergy Decision and Mobile Empowerment (PADME): Patient engagement and delabeling outcomes	90
Investigating the Effect of Dupilumab on Specific Immunoglobulin-E (sIgE) Levels in Children with IgE-mediated Food Allergy	89
Isolated Perinatal Antibiotic Exposure Due To Maternal GBS And The Risk For Childhood Asthma	88
Reduction in Asthma Exacerbations Following Initiation of Benralizumab Among Medicare Beneficiaries: Results from the ZEPHYR-5 Study	88
CCR8 May Be An Important Receptor for CCL17 on Regulatory T-cells	86
House Dust Mite Extract Blocks IRF3 Activation In Respiratory Epithelial Cells	85
Wheat Dependent Exercise Induced Anaphylaxis (WDEIA)- Spotting Patterns In The Unique!	85
Low Regulatory T cells and Insufficiency of Serum vitamin D in Urticarial Vasculitis Patients in Ukraine	84
Systemic Treatments For Severe Eczema: A Cost-Effectiveness Study	84
Identification of bronchial epithelial genes associated with type 2 eosinophilic inflammation in asthma	83
A Systematic Literature Review of Real-World Anti-Interleukin-5 and Anti-interleukin-5 Receptor Alpha Treatment Outcomes for Hypereosinophilic Syndrome: Case Reports and Cohort Studies	83
Utility of a Validated Disease-Specific Measure to Assess Symptomology in Patients with Indolent Systemic Mastocytosis (ISM)	80
Exploring the association between Adverse Childhood Experiences and atopic dermatitis	78
Combined IFN-γ and JAK inhibition to treat hemophagocytic lymphohistiocytosis in mice	77
A Retrospective Chart Review Evaluating Adherence to Biologic Therapy in Patients with Severe Asthma Seen in a Pediatric Tertiary Care Center	77
Feasibility of capturing self-reported asthma exacerbations with a digital self-management platform	77
Editorial Board	76
Symptomatology and Diagnostic Journey of Patients Diagnosed with Systemic Mastocytosis in The US Oncology Network	75
The Impact of the COVID-19 Pandemic on Food Allergy Families	75
Clinical and Sensitization Profile in Peach Allergy due to LTP Sensitization	74
Clinical Manifestations and Phenotypic Characterization of Older-Adult-Onset Common Variable Immunodeficiency	74
Clinical Characterization of Unresolved vs Resolved Chronic Cough Evaluated in a Primary Care Clinic	73
Improve Eczema/Asthma Research Study Enrollment and Retention Using Engaging, Participant Co-designed Graphic-Style Stories	73
Use of Basophil Activation Test in Peach Allergy Diagnosis	72
A powerful tool with a narrow focus: Aiming genome-wide association studies at chronic spontaneous urticaria	72
A novel ambient air sampling device for detection of major indoor and food aeroallergens	72
Impact of biologics on revision sinus surgery numbers in CRSwNP patients in a tertiary care center in Belgium.	72
Brief Overview of This Month's JACI	72
Hypogammaglobulinemia and Risk of Infectious Complications in Patients Receiving Idecabtagene vicleucel	70
Statin or PCSK9 Blocking Alleviate Airway Hyperresponsiveness and Lung Fibrosis In High Fat Diet Induced Obesity Mice	69
Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study	68
In-Depth Serum Proteomic Analysis of Food Protein-Induced Enterocolitis Syndrome Reveals Dynamics of Platelet and Neutrophil Activation Responses and Biomarker Candidates	68
Title Page	67
Differential Expression of B cell Populations in Alpha-Gal Allergic Patients	67
CME Calendar-AAAAI	67
Risk Stratification of Food Allergy Patients: Results from the International, Cross-sectional Prevalence and Severity Study of Pediatric and Adult IgE-Mediated Food Allergies (ASSESS FA)	67
Airway transcriptome networks identify susceptibility to frequent asthma exacerbations in children	66
Impact Of Exacerbation History On Dupilumab Efficacy In Children With Asthma In The VOYAGE Study	66
Long-term Efficacy and Safety of Benralizumab Treatment for PDGFRA-negative Hypereosinophilic Syndrome	65
Dupilumab Reduces T cell Antigen-Specific Response in Eosinophilic Esophagitis	65
Real-World Outcomes After Switching to Immune Globulin Subcutaneous 16.5% In Patients with Primary Humoral Immunodeficiency: A 3-Year Study	64
Efficacy Of Ipratropium Bromide/Albuterol Compared To Home Metered-Dose Inhalers For Inpatient Management Of Asthmatics	64
Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1 Antihistamines	64
The Brazilian Registry for Hereditary Angioedema: insights from the first 283 Patients	64
A Replicate Phase III Clinical Trial to Assess the Reproducibility of Efficacy and Safety of Reproxalap Ophthalmic Solution (0.25%) Compared to Vehicle in Participants With Seasonal Allergic Conjuncti	64
Local Oral Immune Responses May Predict the Clinical Course of Covid 19 Infections	63

First-in-human Safety, Pharmacokinetics and Pharmacodynamics of THB001: An Orally Available, Potent and Highly Selective Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase	63
Heterogeneity of CD4+ T cell subsets in EoE drives inflammation and B cell help	62
Efficacy and Safety of House Dust Mite Sublingual Immunotherapy Tablet for Allergic Rhinoconjunctivitis in Subjects ≥50 Years	62
Association between Leukotriene A4 Hydrolase Genetic Variants and Urticaria/Angioedema to Nonsteroidal Anti-inflammatory Drugs	61
CME Calendar-AAAAI	61
Garlic Allergy	61
Evaluation of the clinical, demographic and inflammatory characteristics of a Spanish cohort of patients with asthma-COPD overlap syndrome.	61
Clinical Features Associated with a Treatment-Refractory Phenotype in Chronic Spontaneous Urticaria (CSU)	61
Real-Life Patterns of Biologic Use and Switch for Severe Asthma at a Major County Hospital	61
Using DEtection TRansformer (DETR) model to automate creation of pollen detection training sets	60
Burden of Illness in Female and Male Adult Patients With Hereditary Angioedema: Findings From a Multinational Survey	60
Nasal and Amnion Methylomes: Biomarkers for Smoke Exposure and Maternal Asthma	60
Oral Presenter Views on Feedback at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting	59
Needs Assessment for Interactive Curriculum on Peanut Allergy Prevention Guidelines	59
Dermographometer Assessment in Children with Urticaria	59
IgE Binding and Cross-reactivity to Linear and Conformational Epitopes of Peanut and Walnut Vicilin-buried Peptides	59
Prospective study to analyze the synergistic effect of amoxicillin and lipopolysaccharide in basophil activation to improve the diagnosis of IgE-mediated hypersensitivity reactions to amoxicillin	57
Mepolizumab Is Efficacious in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With One or Multiple Prior Nasal Polyps (NP) Surgeries: SYNAPSE Outcomes	57
CME Calendar-AAAAI	56
Dupilumab Reduction of IgE Levels and Probability of Atopic Dermatitis Flares – Analysis of A Randomized Placebo-Controlled 52-Week Study	56
Effect of Pre-existing Atopic Disease on Pediatric Peanut Sublingual Immunotherapy (SLIT) Outcomes	56
Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication	56
Heterogeneity and molecular mechanisms of early-life wheeze	56
IL-4R alpha Blockade Reduces the Frequency and Severity of Food-induced Anaphylaxis in a Murine Model of Oral Immunotherapy	55
Long-Term Maintenance of Peanut Oral Immunotherapy in Patients Ages 4 and Older	55
Development of a multifunctional third generation anti-IgE therapeutic candidate antibody	54
Long-term effectiveness of peanut oral immunotherapy: beyond bite protection	54
The Challenge Of When To Challenge: An Investigation Into Aspirin-Exacerbated Respiratory Disease (AERD) Screening Methodology	54
Epinephrine Autoinjectors Use Technique Assessment and Resident Education	54
Development of a Mobile Naturalistic Exposure Chamber for Cat Dander	54
mTORC1 regulates airway epithelial cytokine generation in CRSwNP	54
Rhinovirus increases Moraxella catarrhalis adhesion to the respiratory epithelium	53
Patients with Pseudoallergic Reactions Following COVID-19 Vaccination are Able to Tolerate Subsequent Dosing	52
Increasing SARS-CoV-2 Vaccine Counseling by Fellows in the Allergy Clinic	52
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Exploratory Study of Omalizumab for Treatment of Idiopathic Angioedema in Patients Who Remain Symptomatic Despite Current Therapy	52
Latino CRS Patients Have Comparable Outcomes to White Patients Before and After Treatment of CRS	52
Baked Egg and Baked Milk Oral Desensitization Outcomes in a Pediatric Cohort	52
Editorial Board	52
Are skin microbes with lantibiotic biosynthesis genes reduced in atopic dermatitis subjects who are culture positive for Staphylococcus aureus?	51
Outcomes of Penicillin Allergy Testing in Children with High-Risk Reaction Histories	51
Editorial Board	51
Efficacy of add-on therapy with intravenous immunoglobulin in steroid hypo-responsiveness DRESS syndrome	51
Household-Wide Food Allergen Exclusion Practices Among Families with Food Allergies	50
PCORI Engagement: Black People Like Me	50
Author Disclosures for Late-Breaking Abstracts	50
Factors Affecting Adaptation of the AAAAI Picture-based Asthma Action Plan: a Survey-Based Study	50
A Multicentre UK-Based Audit on Acquired C1 Inhibitor Deficiency 2021	50
In silico exploration of atopic dermatitis phenotypes for clinical trial design optimization	49
Allergy In Early Childhood Is A Risk Factor For The Development Of Attention Deficit Hyperactivity Disorder (ADHD)	49
COVID-19 Infection Outcomes In Inner-City Asthmatics	49
Real-world Dupilumab Use in a Pediatric Allergy Clinic	48
Iowa Pollen Counts During a Derecho Wind Storm and Autumn Weed Pollen Seasons	48
LIGHT Deficiency Protects Against Esophageal Remodeling In A Murine Model Of Chronic Eosinophilic Esophagitis	48
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease	47
Basophil-VAMP7 is a vital regulator of skin barrier integrity and chronic itch	47
Reply	47
Small proline-rich protein 2A drives epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps via SAA2 upregulation	47
Disease-associated mutations in topoisomerase IIβ result in defective NK cells	47
Reply	47
Leveraging artificial intelligence for medical education in allergy and immunology	46
Optimizing investigation of suspected allergy to polyethylene glycols	46
Sensory neuroimmune signaling in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis	46
Protective Role of Intranasal Methylcellulose Powder Against Nasal Inflammatory Episodes in Children Attending Daycare Facilities	46
Increasing wildfire smoke from the climate crisis: Impacts on asthma and allergies	46
Study of stereotyped, allergen-specific IgE sequences from specific immunotherapy participants yields new insight into mechanisms of allergy suppression	45
Association of the gut microbiome and metabolome with wheeze frequency in childhood asthma	45
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop	45
Table of Contents	45
Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT	45
Corrigendum	45
The circadian metabolome of atopic dermatitis	45
NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome	44
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control	44
Editorial Board	44
Please push the peanuts!	44
Basophil activation test as an useful predictive tool for assessing effective tolerant response to Pru p 3 sublingual immunotherapy in patients with lipid transfer protein allergy.	44
Obesity and hormonal influences on asthma: Mechanisms, management challenges, and emerging therapeutic strategies	44
T follicular helper cells in primary immune regulatory disorders	43
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy	43
Meta-analysis of ACE inhibitor–induced angioedema identifies novel risk locus	43

Antigen-specific immune responses and microbiota interactions in skin: Insights into autoimmune skin diseases and emerging therapeutic strategies	43
Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutations	42
Central trained immunity and its impact on chronic inflammatory and autoimmune diseases	41
Periostin promotes inflammation and neovascularization in atopic keratoconjunctivitis	41
Contribution of genetic variants associated with primary immunodeficiencies to childhood-onset systemic lupus erythematous	41
Diagnostic merits of the Eosinophilic Esophagitis Diagnostic Panel from a single esophageal biopsy	41
Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies	40
Updates on immune mechanisms in aspirin-exacerbated respiratory disease	40
Chronic spontaneous urticaria guidelines: What is new?	40
Mechanisms of airway disease development following inhalation exposure to indoor fungal contaminants Stachybotrys chartarum and Aspergillus versicolor	40
Corrigendum	40
Reply	40
Mast cell chymase regulates extracellular matrix remodeling-related events in primary human small airway epithelial cells	40
Environmental justice and allergic disease: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee and the Diversity, Equity and Inclusion Committee	40
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation	40
Multiomics analysis identified IL-4–induced IL1RL1high eosinophils characterized by prominent cysteinyl leukotriene metabolism	39
Efficacy and safety of baked milk oral immunotherapy in children with severe milk allergy: A randomized, double-blind, placebo-controlled phase 2 trial	39
Multilayer concept of autoimmune mechanisms and manifestations in inborn errors of immunity: Relevance for precision therapy	39
Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study	39
Patterns of Cost-related Medication Non-Adherence among Children with Atopic Dermatitis	39
Basophils are important for development of allergic skin inflammation	39
Phospholipid remodeling and its derivatives are associated with COVID-19 severity	39
The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis	38
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials	38
Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity	37
Sputum short-chain fatty acids, microbiome, inflammation, and mucus plugging in obstructive airway disease	37
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial	37
Activated sputum eosinophils associated with exacerbations in children on mepolizumab	37
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count	37
Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps	37
Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma	37
Improving Understanding, Identification, And Treatment Of Anaphylaxis: A Quality Improvement Project	36
Exclusive breast-feeding, the early-life microbiome and immune response, and common childhood respiratory illnesses	36
Defining risk profile groups for severe IgE-mediated food allergy reactions: Severity x QoL Risk Framework from the ASSESS FA study	36
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis	36
PAI-1 genotype and regulation of airway PAI-1 in vivo: relationships with patterns of airway gene expression during illness	36
Neutralizing IL-22RA1 improves histological and molecular alterations associated with atopic dermatitis pathogenesis	36
Alternative Algorithm For Rapid E.coli L-asparaginase Desensitization Via Intramuscular Administration In Children With Acute Lymphoblastic Leukemia: A Single-Center Experience	36
National Demographic Trends and Approval Rates for Omalizumab Use to Treat Food Allergy: A Retrospective Claims-Based Analysis Since FDA Approval	35
Utilization of Complementary and Alternative Medicine Among Children with Food Allergy in the FORWARD Cohort	35
Penicillin Allergy Testing and Clearance in the Operational Setting: An Update	35
Genetic analysis as an important component for diagnosis of Hereditary Angioedema: data from a physician-based Brazilian Registry	35
Dupilumab for pediatric eosinophilic esophagitis	35
Effect of Dupilumab Use for Atopic Dermatitis on Concomitant Food Allergy Clinical Course	34
The coming of age of protein degraders as anti-inflammatory therapeutics	34
Effect of Best Practice Alert with Embedded Clinical Decision Support Tool on Cephalosporin Use in Hospitalized Patients with Penicillin Allergy Labels	34
Mepolizumab Improves Patient-Reported Outcomes and Reduces Treatment Burden in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Real-World Chart Review Study	34
Corrigendum	34
Particulate matter enhances microbial infections by inhibiting the production of antimicrobial peptides	34
Impact of migration on prevalence of atopic disease in immigrant families from southern India to North America across generations	34
The Editors’ Choice	34
Table of Contents	34
CME Calendar-AAAAI	34
A Comparative Evaluation of Quality of Life in Children with Food Allergy Undergoing Oral Immunotherapy (OIT) and Non-OIT Approaches	33
Lebrikizumab Improves Anxiety and Depression Symptoms of Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from a 52-Week, Open-label, Phase 3 Study	33
neffy, epinephrine nasal spray, Demonstrates a Positive Efficacy and Safety Profile for the Treatment of Allergic Reactions in Pediatric Patients at-Risk of Anaphylaxis: Phase 3 Study Results	33
The Editors’ Choice	33
Short-Term Prophylaxis And On-Demand Treatment In HAE-C1INH In The Last Ten Years	33
The Exhalation Delivery System with Fluticasone has Consistent Efficacy Across the Spectrum of Chronic Rhinosinusitis: Pooled Analysis of 4 Placebo-Controlled Trials	33
Lipid Metabolic Reprogramming in Chronic COVID-19 Chemosensory Dysfunction Perpetuates Bitter Taste Distortions	33
Effectiveness of Real-World Peanut Oral Immunotherapy at a Large Tertiary Referral Academic Center	33
Clinical Study Experience Suggests No Impact On Hemostasis Among Patients With Hereditary Angioedema Receiving Garadacimab And Undergoing Surgical/Medical Procedures	33
A retrospective analysis of patients with alpha-gal syndrome receiving heparin products	33
Varying Skin Prick Test Reactivity Frequencies across Dog Epithelium, Acetone Precipitated Dog and Dog Ultrafiltered Extracts	33
Corrigendum	33
Mycobacterium chelonae-Induced Granulomatous Nodules Following Botulinum Toxin Injections: A Case Report and Literature Review	33
Single-cell RNA-seq analysis reveals novel genes and pathways responsive to house dust mite and subject to Tet1 regulation in the lung	32
Ocular Allergic Surface Disease Symptoms Associated with Atopic Keratoconjunctivitis (AKC) Alleviated With Dupilumab	32
Longer Time To Allergist Appointment for Atopic Children on Medicaid	32
Sociodemographic Factors Associated with Outgrowing Food Allergy in Children	32
Real-World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid GERD or Anxiety/Depression: Post Hoc Analysis of REALITI-A	32
Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial	32
Real-World Treatment Patterns and Characteristics of Patients With Hereditary Angioedema Treated With Lanadelumab: Results From a US Retrospective Chart Review Study	32
Serum IL-17, IL-33, and different types of asthma treatments	32
Outcome of Electronic-Consults and Facilitated Follow-up for Inpatient Asthma Exacerbations	31
Direct oral amoxicillin challenge for the outpatient evaluation of brazilian children and adolescents with low risk reactions	31
Neonatal rhinorrhea and elevated heart rate variability predict exercise-induced wheeze at age 4-11 years among females.	31
Evaluation of elevated serum tryptase among individuals with eosinophilic gastrointestinal disorders	31
Factors Associated with Asthma Biologic Prescribing and Adherence Among Adults in a Large Multi-hospital Health System	31
The impact of functional endoscopic sinonasal surgery on oral corticosteroid use and costs over 3 years in patients with chronic rhinosinusitis with nasal polyps in US real-world practice	31
The usefulness of specific IgE to Cod for predicting clinical reactions to cod and other white meat fishes in Korean children	31
Distinct Airway Inflammatory Pathways Associated with Asthma Exacerbations are Modulated by Mepolizumab Therapy in Children	31
Inhibition of Staphylococcus aureus induced mast cells/ basophils activation via regulation of NFkB signaling pathway by small molecule compound berberine.	31
Mental health symptoms are associated with low patient satisfaction among adults with asthma	31
Frequency of Headache in Emergency Department Patients with Anaphylaxis: A Prospective Study	31
A Prospective Study of Intimate Partner Violence, Uncontrolled Asthma, and Inflammatory Pathways: Insights from Cytokine Profiles	30
Depression in older adults with asthma associated with decreased asthma control and increased pro-inflammatory cytokines	30
Component-resolved diagnostics for IgE-mediated milk allergy	30
Risk-Stratification Identifies Low-Risk Fluoroquinolone Allergies Suitable for Direct Oral Challenge	30
The BTK inhibitor acalabrutinib reduces or eliminates clinical reactivity during oral challenge to peanut in allergic adults	30
Parental Awareness and Management of Bullying in Children with Food Allergies	30
Events Supposedly Attributable to Vaccination or Immunization after COVID-19 vaccines in children.	29
Increased Population of CD19+CCR6+ Cells Expressing Intracellular IgE in Alpha-Gal Allergic Patients	29
Asthma Related Disparities In Emergency Department Usage And Clinical Outcomes Among Spanish Speakers	29
The Association Between Child Food Allergy and Food Insecurity in the Family Unit	29